Literature DB >> 8102461

Cardiac effect of halofantrine.

J Karbwang, K Na Bangchang, D Bunnag, T Harinasuta, P Laothavorn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102461     DOI: 10.1016/0140-6736(93)91631-u

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  Potentiation of halofantrine-induced QTc prolongation by mefloquine: correlation with blood concentrations of halofantrine.

Authors:  I D Lightbown; J P Lambert; G Edwards; S J Coker
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

Review 2.  Pharmacokinetic interactions of antimalarial agents.

Authors:  P T Giao; P J de Vries
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 3.  Adverse effects of class I antiarrhythmic drugs.

Authors:  J Caron; C Libersa
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

4.  An investigation of the interaction between halofantrine, CYP2D6 and CYP3A4: studies with human liver microsomes and heterologous enzyme expression systems.

Authors:  R C Halliday; B C Jones; D A Smith; N R Kitteringham; B K Park
Journal:  Br J Clin Pharmacol       Date:  1995-10       Impact factor: 4.335

5.  The antimalarial drug halofantrine is bound mainly to low and high density lipoproteins in human serum.

Authors:  B Cenni; J Meyer; R Brandt; B Betschart
Journal:  Br J Clin Pharmacol       Date:  1995-05       Impact factor: 4.335

6.  Stereoselective halofantrine disposition and effect: concentration-related QTc prolongation.

Authors:  D R Abernethy; D L Wesche; J T Barbey; C Ohrt; S Mohanty; J C Pezzullo; B G Schuster
Journal:  Br J Clin Pharmacol       Date:  2001-03       Impact factor: 4.335

7.  Plasma concentrations of the enantiomers of halofantrine and its main metabolite in malaria patients.

Authors:  F Gimenez; C Gillotin; L K Basco; O Bouchaud; A F Aubry; I W Wainer; J Le Bras; R Farinotti
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 8.  Adverse effects of chemotherapeutic agents used in tropical medicine.

Authors:  G C Cook
Journal:  Drug Saf       Date:  1995-07       Impact factor: 5.606

9.  Halofantrine pharmacokinetics in Kenyan children with non-severe and severe malaria.

Authors:  W M Watkins; P A Winstanley; E K Mberu; G Kokwaro; S A Murphy; C J Newton; I Mwangi; D Forster; K Marsh
Journal:  Br J Clin Pharmacol       Date:  1995-03       Impact factor: 4.335

Review 10.  Fatal cardiotoxicity related to halofantrine: a review based on a worldwide safety data base.

Authors:  Olivier Bouchaud; Patrick Imbert; Jean Etienne Touze; Alex N O Dodoo; Martin Danis; Fabrice Legros
Journal:  Malar J       Date:  2009-12-10       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.